BioAge Labs BIOA
NASDAQ BIOA
$9.68 -1.07 (-9.95%)
As of: Aug 20, 2026 · 3:56 PM EDT

BioAge Labs (BIOA) EBIT Margin Growth (1y) (2026)

BioAge Labs (BIOA) EBIT Margin Growth (1y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Haleon 43.85 Bn 42.88 Bn - -
2 Teva Pharmaceutical Industries 43.02 Bn 39.37 Bn 2.15 Bn -1,647.00
3 Zoetis 31.47 Bn 29.79 Bn 1.05 Bn -368.00
4 Takeda Pharmaceutical 28.59 Bn 22.79 Bn 5.10 Bn -17.00
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn -341.00
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -634.00
7 Neurocrine Biosciences 15.45 Bn 15.06 Bn 935.80 Mn -538.00
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 40.00
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn - -
10 BioAge Labs 434.04 Mn 434.04 Mn -14.23 Mn -16,979.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -16,979.00
Mar 31, 2026 21,802.00